| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031131 |
| Receipt No. | R000035560 |
| Official scientific title of the study | Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded to non-surgical treatment favorably. |
| Date of disclosure of the study information | 2018/02/07 |
| Last modified on | 2018/07/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Survival benefit of conversion surgery for patients with initially unresectable pancreatic cancer who responded to non-surgical treatment favorably. | |
| Title of the study (Brief title) | Conversion surgery for patients with UR-PC | |
| Region |
|
|
| Condition | ||
| Condition | unresectable pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We analyzed outcomes of conversion surgery (CS) for patients with unresectable pancreatic cancer (UR-PC), and evaluated the survival benefit of CS. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | I) Patients diagnosed as unresectable pancreatic cancer
II) Patients with favorable responses to non-surgical treatment III) Patients who underwent conversion surgery IV) Patients who refuse to participate in this research |
|||
| Key exclusion criteria | Patients judged inappropriate as research subjects by research managers | |||
| Target sample size | 34 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Hirano |
| Organization | Hokkaido University Faculty of Medicine |
| Division name | Department of Gastroenterological Surgery II |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido |
| TEL | 011-706-7714 |
| satto@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Toshimichi Asano |
| Organization | Hokkaido University Faculty of Medicine |
| Division name | Department of Gastroenterological Surgery II |
| Address | N-15, W-7, Kita-ku, Sapporo, Hokkaido |
| TEL | 011-706-7714 |
| Homepage URL | |
| toasa0616@gmail.com | |
| Sponsor | |
| Institute | Hokkaido University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.ncbi.nlm.nih.gov/pubmed/29797499 |
| Results |
|
| Other related information | Background information: age, sex, medical history,
Non-surgical treatment information: treatment, drug used, treatment period, treatment effect judgment Tumor marker: CEA, CA19-9 Surgical information: operative method, operation time, amount of bleeding Postoperative information: postoperative complication, postoperative hospital stay Information on postoperative information: presence or absence of postoperative adjuvant chemotherapy (drug, duration) Presence or absence of recurrence (presence or absence of treatment, content, duration), presence / absence of death, cause of death |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035560 |